3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
3
Recruiting
2
Terminated
1
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Myeloid
1
Genitourinary
1
Conditions
Colorectal Neoplasms
4
Venous Thromboembolism
2
Thrombocythemia, Essential
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Ovarian Neoplasms
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Hemorrhage
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Breast Neoplasms
1
Interventions
apixaban
8
Rivaroxaban
4
Heparin, Low-Molecular-Weight
2
Enoxaparin
2
Aspirin
2
isoquercitrin
1
enoxaparin sodium
1
N(4)-oleylcytosine arabinoside
1
Educational Status
1
Anticoagulants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Venous Thromboembolism
×
Aspirin
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled
NCT06866964
2026-02-02
ASPIRE
Wake Forest University Health Sciences
Phase 2
Recruiting
35 enrolled